Medroxyprogesterone (Provera, Depo-Provera Sterile Aqueous) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 23, 2026
Also sold as: Provera, Depo-Provera Sterile Aqueous, Depo-Provera
Some Medroxyprogesterone products are in shortage in Canada (1 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
A progestin hormone used for birth control and to treat menstrual and hormonal conditions.
Products affected
1 / 14
In shortage since
Jul 14, 2026
Est. full return
Aug 7, 2026
Reports on file
64
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
AA-MEDROXY
10MG · TABLET · AA PHARMA INC
DIN 02277298 · since Jul 14, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Resolved
AA-MEDROXY
100MG · TABLET · AA PHARMA INC
DIN 02267640 · ended Nov 25, 2025 · Disruption of the manufacture of the drug.
Discontinued
PROVERA 10MG TABLETS
10MG · TABLET · PFIZER CANADA ULC
DIN 00729973
Discontinued
PROVERA 2.5MG TABLETS
2.5MG · TABLET · PFIZER CANADA ULC
DIN 00708917
Resolved
AA-MEDROXY
100MG · TABLET · AA PHARMA INC
DIN 02267640 · ended Aug 6, 2025 · Disruption of the manufacture of the drug.
Resolved
AA-MEDROXY
10MG · TABLET · AA PHARMA INC
DIN 02277298 · ended Aug 6, 2025 · Disruption of the manufacture of the drug.
Discontinued
PROVERA 5MG TABLETS
5MG · TABLET · PFIZER CANADA ULC
DIN 00030937
Avoided
PROVERA 5MG TABLETS
5MG · TABLET · PFIZER CANADA ULC
DIN 00030937 · ended Jun 4, 2025 · Disruption of the manufacture of the drug.
Avoided
PROVERA 2.5MG TABLETS
2.5MG · TABLET · PFIZER CANADA ULC
DIN 00708917 · ended Jun 4, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-MEDROXYPROGESTERONE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02221306
Discontinued
TEVA-MEDROXYPROGESTERONE
5MG · TABLET · TEVA CANADA LIMITED
DIN 02221292
Discontinued
TEVA-MEDROXYPROGESTERONE
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 02221284
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Medroxyprogesterone is currently affected by an active shortage report filed with Health Canada by AA PHARMA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Medroxyprogesterone is classified under “PROGESTOGENS” (ATC G03DA).
Recent changes
Jul 23, 2026
Estimated end date pushed back : Jul 31, 2026 → Aug 7, 2026
Jul 16, 2026
New report filed
Common questions
What is Medroxyprogesterone used for?
A progestin hormone used for birth control and to treat menstrual and hormonal conditions.
When will Medroxyprogesterone be back in stock in Canada?
The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Medroxyprogesterone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.